tiprankstipranks
Trending News
More News >
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (HK:2185)
:2185
Hong Kong Market

Compare Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (2185) vs. Competitors

Compare
0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
HK$5.71
HK$1.28B
-13.25
192.22%
Genor Biopharma Holdings Limited
HK$3.06
HK$5.02B
56.31
32.98%
TOT BIOPHARM International Co. Ltd.
HK$2.50
HK$3.18B
392.38
116.84%
Zhaoke Ophthalmology Ltd.
HK$3.17
HK$2.02B
-6.68
164.75%
Immunotech Biopharm Ltd
HK$2.68
HK$1.60B
-6.01
2.82%
Hightide Therapeutics Inc
HK$3.05
HK$1.36B
-3.85
135.09%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2185
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
5.26
3.56
209.41%
HK:6998
Genor Biopharma Holdings Limited
2.50
0.62
32.98%
HK:1875
TOT BIOPHARM International Co. Ltd.
4.12
2.28
123.91%
HK:6622
Zhaoke Ophthalmology Ltd.
3.68
2.34
174.63%
HK:6978
Immunotech Biopharm Ltd
2.59
0.09
3.60%
HK:2511
Hightide Therapeutics Inc
2.68
1.55
137.17%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts